Category: Coronavirus

Moral Injury during COVID-19. St Emlyn’s

Ed – We have previously covered the concept of moral injury on the blog and podcast, largely in respect to the experience of managing patients with traumatic injury. In 2020 the concept has been used

JC: Lopinavir/Ritonavir in the treatment of COVID-19

We have been following the RECOVERY trial closely over the last few months. It’s the largest RCT of therapeutics for COVID-19 in the world and it’s already shown that hydroxychloroquine and azithromycin don’t work in

azithromycin stemlyns covid-19

JC: Azithromycin in patients hospitalised with COVID-19

As we near the end of 2020, it is worth taking a moment to reflect on what a year it has been. At the beginning of the year we were first hearing about a respiratory

St Emlyn's November December Podcast 2020

Christmas 2020 Round Up Podcast. St Emlyn’s

Welcome to our audio round up of everything on the blog during November and the first half of December. It’s been a COVID heavy month which reflects some of the great research that we are

The Emerging Evidence for a Genetic Susceptibility to Severe Covid-19. St Emlyn’s

A defining feature of the COVID-19 pandemic has been the wide spectrum of clinical presentations, ranging from asymptomatic viremia to life-threatening illness.1 Factors such as advancing age and co-morbid status have been shown to strongly correlate

Risk stratification in the ED for COVID19 patients: The PRIEST study. St Emlyn’s

A core skill in emergency medicine is in the identification and classification of risk categories for the patients we see. For many conditions we have derived, validated and refined scoring systems over many years (for

Tocilizumaybe? Immune modulation in COVID-19 @StEmlyns

I am sure many of you saw the breaking news on the BBC the other week, about a new wonderdrug to strengthen our defences against the tidal wave that is COVID19. This follows a press

COVID-19 testing

Understanding COVID-19 testing with Rick Body. St Emlyn’s

This week Simon and Rick got together to talk through the latest technologies, uses and performance of COVID-19 testing. We think it’s a really useful listen to understand the strengths and weaknesses of the various

JC: Convalescent plasma in COVID 19 patients.

This month the BMJ has published a trial on the use of convalescent plasma in the treatment of admitted patients with COVID-19 (the PLACID trial). Convalescent plasma therapy basically takes plasma, together with antibodies from

CODA Zero episodes now open access.

I’m not sure whether you have noticed, but the first two episodes of the CODA Zero program are now live on their website. If you did not already know, the CODA project is designed to

Translate »